Search
01/03/2026
Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes
Gonzalez-Manzanares, R, Anguita-Gámez, M, Muñiz, J, Barrios, V, Gimeno-Orna, JA, Pérez, A, Rodríguez-Padial, L, Anguita, M. Sex Differences in the Diagnosis and Management of Heart Failure Among Outpatients with Type 2 Diabetes. JOURNAL OF WOMENS HEALTH. 2026; 35(3)DOI:10.1177/15409996251401741. PMID:41449991. IF:1.900(Q1/2D).
01/03/2026
Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC
Paz-Ares, L, Veillon, R, Majem, M, Zhou, CC, Tang, KJ, Kim, SW, Richardson, G, Girard, N, Sanborn, RE, Mansfield, AS, Park, K, Schuchard, J, Diels, J, Sermon, J, Bhattacharya, A, Lorenzini, P, Wortman-Vayn, H, Knoblauch, RE, Agrawal, T, Baig, M, Ono, A, Sabari, JK. Patient-reported outcomes and time to symptomatic progression from PAPILLON: amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated advanced NSCLC. LUNG CANCER. 2026; 213DOI:10.1016/j.lungcan.2025.108788. PMID:41671629. IF:4.400(Q1/2D).
01/03/2026
Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease
Dominguez-González, C, Iannucci, D, Clark, J, Martin-Jiménez, P, Hold, S, Oliva, P, Bischinger, A, Gallardo, E, Diaz-Manera, J. Urinary glucose tetrasaccharide tracks disease activity in late-onset Pompe disease. NEUROMUSCULAR DISORDERS. 2026; 60DOI:10.1016/j.nmd.2026.106359. PMID:41638029. IF:2.800(Q2/5D).
01/03/2026
Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood
Pérez-González, R, Vázquez-Oliver, A, Rivas-Asensio, E, Campolongo, A, Pons-Pons, G, Martínez-Horta, S, Pagonabarraga, J, Pascual-Sedano, B, Kulisevsky, J. Motor fluctuations in Parkinson's disease leave a distinct immune fingerprint in blood. PARKINSONISM & RELATED DISORDERS. 2026; 144DOI:10.1016/j.parkreldis.2026.108208. PMID:41643584. IF:3.400(Q2/3D).
01/03/2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Garcia-Castro, J, Vandevrede, L, Donohue, MC, Vaqué-Alcázar, L, Rubio-Guerra, S, Selma-González, J, Heuer, HW, Morcillo-Nieto, AO, Franquesa, M, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Abdelnour, C, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Sala, I, Lleó, A, Gorno-Tempini, ML, Mandelli, ML, Raman, R, Wills, AM, Barragan, E, Litvan, I, Boeve, B, Dickerson, B, Grossman, M, Huey, ED, Irwin, DJ, Pantelyat, A, Tartaglia, C, Rojas, JC, Boxer, AL, Illán-Gala, I. Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. JPAD-Journal of Prevention of Alzheimers Disease. 2026; 13(3)DOI:10.1016/j.tjpad.2026.100486. PMID:41581260. IF:7.800(Q1/1D).
01/03/2026
Atypical Anti-Glomerular Basement Membrane Disease
Fernández-Lorente, L, Shabaka, A, Mora-Gutiérrez, JM, Caravaca-Fontán, F, Maldonado-Martin, M, Cabello, V, Marco, H, Temprado, A, Rivera, C, Facal, L, Barros, X, Manrique, J, Santos, AP, Fernández-Juárez, G, González, CC. Atypical Anti-Glomerular Basement Membrane Disease. Kidney International Reports. 2026; 11(3)DOI:10.1016/j.ekir.2025.103732. PMID:41584267. IF:5.700(Q1/1D).
01/03/2026
SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department
Agra Montava, I, Motos Bescos, M, Moline Parejay, A. SGLT2 inhibitors in acute heart failure: Intermediate eGFR stratum, potential biases, and applicability in the Emergency Department. MEDICINA CLINICA. 2026; 166(3)DOI:10.1016/j.medcli.2025.107332. PMID:41604866. IF:2.100(Q2/3D).
01/03/2026
Dose Mapping Using Image Registration for Reirradiation: A Systematic Review
Thiongo, CM, Davey, A, Appelt, A, Day, M, Dupuis, P, Monti, S, Perez-Alija, J, Skopidou, T, Svensson, S, Osorio, EV. Dose Mapping Using Image Registration for Reirradiation: A Systematic Review. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2026; 124(3)DOI:10.1016/j.ijrobp.2025.09.053. PMID:41083027. IF:6.500(Q1/1D).
01/03/2026
Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology
Puig, L, Carrascosa, JM, Rivera, R, Vilarrasa, E, de la Cueva, P, López-Ferrer, A. Generalized Pustular Psoriasis: Review and Consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104544. PMID:41371399. IF:(Q/D).
01/03/2026
Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study
Mansilla-Polo, M, Pons-Benavent, M, Fernández-Crehuet, P, Vilarrasa, E, Albanell-Fernández, C, Morales-Tedone, E, Rausell-Félix, F, Alcalá-Garcia, R, Matellanes-Palacios, M, Martin-Ezquerra, G, Alfageme, F, Ciudad-Blanco, C, López-Villaescusa, MT, Segura-Palacios, JM, Pascual-Ramirez, JC, Fernández-Diaz, ML, Falkenhain-López, D, Garcia-Gil, M, Agusti-Mejias, A, No-Pérez, N, Naranjo-Guerrero, N, Estenaga-Pérez, A, Garcia-Ruiz, R, Mahiques-Santos, L, Garbayo-Salmons, P, Martorell, A, Escutia-Muñoz, B, Martin-Torregrosa, D, Cuenca-Barrales, C, Paniego, CU, Botella-Estrada, R, Molina-Leyva, A. Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study. Actas Dermo-Sifiliograficas. 2026; 117(3)DOI:10.1016/j.ad.2025.104531. PMID:41354335. IF:(Q/D).
01/03/2026
Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024
Grau-Pérez, M, Mercader-García, P, Giménez-Arnau, AM, Sanz-Sánchez, T, Ninet, VZ, Guijarro, SC, Miquel, FJM, Salvador, JFS, González-Pérez, R, González, IR, Baldrich, ES, Carrascosa, JM, de Frutos, FJO, Serna, MR, Ortega, MEG, Suárez, CP, Triviño, FJN, Chicharro, P, Andreu, M, Gilo, AS, Rodríguez, JJP, Nieto, MAP, Melé-Ninot, G, Guillén, PS, de la Fuente, EG, Elosua-González, M, Munera-Campos, M, Romero, FT, Descalzo, MA, Borrego, L. Anogenital Contact Dermatitis in Spain: A REIDAC Study of Patients Undergoing Patch Testing in 2019-2024. CONTACT DERMATITIS. 2026; 94(3)DOI:10.1111/cod.70048. PMID:41365615. IF:4.600(Q1/1D).
01/03/2026
Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review
Calvo-Río, V, Secada-Gómez, C, Gutiérrez, AM, Retuerto-Guerrero, M, Font, J, Casafont-Solé, I, Mayo-Juanatey, A, Sancho, JJA, Freites, D, Hormigos, C, Puñal, NG, Arribas, GG, Sanchez, JRM, García-Valle, A, Ibañez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cortes-Hernandez, J, Sanchez, DP, Lojo, L, Pérez, ECC, Collado, P, Larios, CA, Icardo, LS, Labrador-Sánchez, E, Peralta-Ginés, C, Onaindia, IU, Plaza-Aulestia, N, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrián-Méndez, L, Pages, FAA, Riazuelo, JRL, Canales, MDF, Hernández, MJA, Bufort, MG, Pàmies, A, de Ardanaz, LS, Aguirre-del-Pino, R, Lefler, JAC, Seijas-Lopez, A, Cubero, MDC, Cofiño, ALC, Ortiz-Santamaria, V, Piñeiro, ML, Calvo, CO, Lopez, CA, Urruticoechea-Arana, A, Magallon, BG, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy-García, AM, Vilamajo, IR, Martos, AG, Lopez, BPM, Urmeneta, GS, Martín, CC, Riera, E, Bejerano, C, Castañeda, S, Blanco, R. Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review. RMD Open. 2026; 12(1)DOI:10.1136/rmdopen-2025-006549. PMID:41856562. IF:4.700(Q1/1D).
01/03/2026
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
Agmon-Levin, N, Ignatenko, S, Gordienko, A, Cortés-Hernández, J, Narongroeknawin, P, Romanowska-Próchnicka, K, Shen, N, Ciferska, H, Kodera, M, Cheng-Chung, WJ, Leszczynski, P, Lan, JL, Mysler, E, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Lie, D, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, López, BPM, Ghanshani, SA, Lau, C, Avrameas, A, Sips, C, Oliver, SJ. B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment. ANNALS OF THE RHEUMATIC DISEASES. 2026; 85(3)DOI:10.1016/j.ard.2025.11.015. PMID:41353079. IF:20.600(Q1/1D).
01/03/2026
Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients
Loricera, J, Molina-Collada, J, Nieto, JC, Sánchez-Lucas, M, Silva-Díaz, MT, Moya, P, Labrador, E, Ferraz-Amaro, I, Blanco, R. Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients. DRUGS & AGING. 2026; 43(3)DOI:10.1007/s40266-026-01281-1. PMID:41714460. IF:3.800(Q2/3D).
01/03/2026
Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease
Dominguez-González, C, Romero, MAB, Eraso, CC, de las Heras, J, Muñoz, EF, Garcia-Campos, O, González, M, Grau, JM, Hernández-Voth, A, Morales, RJ, Hernández, JCL, Martos, ML, López-Padilla, D, Muelas, N, Nascimento, A, Olivé, M, Paradas, C, Fernández, JP, Pascual, SI, Pitarch, I, Sancho, J, Diaz-Manera, J. Recommendations for the diagnostic, treatment, and follow-up of late-onset Pompe disease. NEUROLOGIA. 2026; 41(2)DOI:10.1016/j.nrl.2025.501933. PMID:41453611. IF:3.100(Q2/4D).
01/03/2026
Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial
Doneddu, PE, Collet-Vidiella, R, Gallo, C, Cocito, D, Manganelli, F, Falzone, Y, Dalla Bella, E, Benedetti, L, Mazzeo, A, Peci, E, Spina, E, Strano, C, Germano, F, Gentile, L, Liberatore, G, Cutellè, C, Bianchi, E, Querol, L, Nobile-Orazio, E. Effect of Rituximab on Neurofilament Levels in CIDP: Results From the CIDPRIT Randomized Trial. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2026; 31(1)DOI:10.1111/jns.70107. PMID:41649095. IF:3.200(Q2/4D).
01/03/2026
Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain
De Pedro, S, Presa, M, Gamez, J, Fernández, FJG, Querol, L. Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain. Pharmacoeconomics-Open. 2026; 10(2)DOI:10.1007/s41669-025-00633-8. PMID:41528376. IF:(Q/D).
01/03/2026
Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study
Font, MA, García-Sánchez, SM, Mengual, JJ, Avellaneda, C, Boned, S, Doncel-Moriano, A, Urra, X, Camps-Renom, P, de la Ossa, NP, Terceño, M, Yugueros, B, Ustrell, X, Purroy, F, Rodríguez-Campello, A, Molina, C, Krupinski, J, Aguirre, GF, Baraldes, M, Jiménez-Fàbrega, X, Salvat-Plana, M, Elosua, R, Abilleira, S, Cardona, P, Gómez-Choco, M. Early neurological deterioration before endovascular treatment in patients with mild stroke. MINORCAT-END-EVT study. Journal of Stroke & Cerebrovascular Diseases. 2026; 35(3)DOI:10.1016/j.jstrokecerebrovasdis.2026.108584. PMID:41679406. IF:1.800(Q3/7D).
01/03/2026
Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model
Goya-Maldonado, R, Erwin-Grabner, T, Zeng, LL, Ching, CRK, Aleman, A, Amod, AR, Basgoze, Z, Benedetti, F, Besteher, B, Brosch, K, Bülow, R, Colle, R, Connolly, CG, Corruble, E, Couvy-Duchesne, B, Cullen, K, Dannlowski, U, Davey, CG, Dols, A, Ernsting, J, Evans, JW, Fisch, L, Fuentes-Claramonte, P, Gonul, AS, Gotlib, IH, Grabe, HJ, Groenewold, NA, Grotegerd, D, Hahn, T, Hamilton, JP, Han, LKM, Harrison, B, Ho, TC, Jahanshad, N, Jamieson, AJ, Karuk, A, Kircher, T, Klimes-Dougan, B, Koopowitz, SM, Lancaster, T, Leenings, R, Li, M, Linden, DEJ, Macmaster, FP, Mehler, DMA, Meinert, S, Melloni, E, Mueller, BA, Mwangi, B, Nenadic, I, Ojha, A, Okamoto, Y, Oudega, ML, Penninx, BWJH, Poletti, S, Pomarol-Clotet, E, Portella, MJ, Radua, J, Rodriguez-Cano, E, Sacchet, MD, Salvador, R, Schrantee, A, Sim, K, Soares, JC, Solanes, A, Stein, DJ, Stein, F, Stolicyn, A, Thomopoulos, SI, Toenders, YJ, Uyar-Demir, A, Vieta, E, Vives-Gilabert, Y, Völzke, H, Walter, M, Whalley, HC, Whittle, S, Winter, N, Wittfeld, K, Wright, MJ, Wu, MJ, Yang, TT, Zarate, C, Veltman, DJ, Schmaal, L, Thompson, PM. Classification of major depressive disorder using vertex-wise brain sulcal depth, curvature, and thickness with a deep and a shallow learning model. MOLECULAR PSYCHIATRY. 2026; 31(3)DOI:10.1038/s41380-025-03273-w. PMID:41044403. IF:10.100(Q1/1D).
01/03/2026
Differential Psychological and Social Impact of the COVID-19 Pandemic on Spanish Youth With and Without Non-Suicidal Self-Injury: A Longitudinal Analysis
Schmidt, C, Otero, D, Pascual, JC, Romero, S, Puntí, J, Lara, A, Sintes, A, Méndez, I, Nicolaou, S, Soler, J, Vega, D. Differential Psychological and Social Impact of the COVID-19 Pandemic on Spanish Youth With and Without Non-Suicidal Self-Injury: A Longitudinal Analysis. ACTAS ESPANOLAS DE PSIQUIATRIA. 2026; 54(2)DOI:10.62641/aep.v54i2.2043. PMID:42023465. IF:1.600(Q3/7D).
01/03/2026
Impact of Cell-Free TNA Fraction on Analytical Success in Liquid Biopsy for Lung Adenocarcinoma: Experience from a Tertiary Hospital
Herrera, IC, Cols, LC, Pijuan-Andujar, L, Cajo, SA, Montalvan, RG, Calvente, MG, Luque, GA, Gallardo, A, Jaramillo, JFC. Impact of Cell-Free TNA Fraction on Analytical Success in Liquid Biopsy for Lung Adenocarcinoma: Experience from a Tertiary Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105990. PMID:. IF:4.200(Q1/1D).
01/03/2026
Serous Tubal Intraepithelial Carcinoma (STIC): Incidence and Clinical Implications in 254 Consecutive Cases from a Tertiary Care Hospital
Misad, C, Cajo, SA, Espadaler, I, Muñoz, R, D'Angelo, E, Gallardo, A, Espinosa, I, Prat, J. Serous Tubal Intraepithelial Carcinoma (STIC): Incidence and Clinical Implications in 254 Consecutive Cases from a Tertiary Care Hospital. LABORATORY INVESTIGATION. 2026; 106(3)DOI:10.1016/j.labinv.2025.105314. PMID:. IF:4.200(Q1/1D).
01/03/2026
ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer
Bruixola, G, Martín-Arana, J, Vidales, Z, Peon, G, Gimeno-Valiente, F, Tous, S, Camblor, DG, Cirauqui, B, García-Bartolomé, M, Sumarroca, A, Martínez-Castedo, B, Leon, X, Micó-García, B, Iglesias-Martínez, B, García-March, A, Segui, V, Pavón, MA, Quirós, B, Clavero, O, Maroñas, M, Escorihuela-Garcia, V, Tarazona, N, Alemany, L, Oliva, M. ctDNA clearance after induction therapy as predictor of response to radical chemoradiotherapy in locally advanced head and neck cancer. RADIOTHERAPY AND ONCOLOGY. 2026; 216DOI:. PMID:. IF:5.300(Q1/2D).
01/03/2026
Cochlear implant failures and complications: What should radiologists look for?
Moreno, EG, Pizarro, MPV, Dotu, CO, Martínez, AL, Escalante, JEM, Beltran, JD. Cochlear implant failures and complications: What should radiologists look for?. Radiologia. 2026; 68(2)DOI:10.1016/j.rx.2025.501685. PMID:. IF:(Q/D).
01/03/2026
Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain
Querol, L, Montoro-Ronsano, JB, Soler-Palacín, P, Galduf, J, Martínez-Pérez, O, Díaz-Cuervo, H. Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2026; 33(3)DOI:10.1111/ene.70570. PMID:41834317. IF:3.900(Q1/3D).
01/03/2026
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
Schmidt-Hieber, M, Ljungman, P, Gilbert, P, Knelange, N, Drozd-Sokolowska, J, Basak, G, Einsele, H, Tridello, G, Abdeljelil, NB, Kulagin, A, Balaguer-Rosello, A, Metafuni, E, Faraci, M, Gozdzik, J, Martino, R, Raiola, AM, Xhaard, A, Kuskonmaz, B, Biffi, A, Czyzewski, K, Gabriel, MA, Martínez-Lopez, J, Zaidman, I, Schlegel, PG, Gruhn, B, Krivan, G, Vicent, MG, Mikulska, M, Peric, Z, Averbuch, D, Styczynski, J, Penack, O, de la Camara, R. Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103792. PMID:41783087. IF:10.000(Q1/1D).
01/03/2026
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects
Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Espinàs, JA, Borras, JM. Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-025-04022-9. PMID:40900393. IF:2.500(Q3/6D).
01/03/2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia
Mecklenbrauck, R, Ramiro, AV, Sträng, E, Gabdoulline, R, Elicegui, JM, Sobas, M, Pleyer, L, Turki, A, Voso, MT, Benner, A, Hernández-Sánchez, A, Tettero, JM, Gimenez, LT, Metzeler, KH, Oñate, G, Lehmann, S, Huntly, BJP, Thomas, I, Thol, FR, Heidel, FH, Valk, PJM, Döhner, K, Haferlach, T, Mills, KI, Döhner, H, Castellani, G, Ossenkoppele, GJ, Hernández-Rivas, JM, Bullinger, L, Heuser, M. Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia. LEUKEMIA. 2026; 40(3)DOI:10.1038/s41375-026-02874-w. PMID:41663622. IF:13.400(Q1/1D).
01/03/2026
The precision of a report on precision
Mur, P, Pozuelo, A, Tabernero, J, Albanell, J, Bellosillo, B, Bosch, F, Briones, J, Brunet, J, Colomer, D, Domènech, M, Fontanet, JM, Matias-Guiu, X, Salazar, R, Vivanco-Hidalgo, RM, Mollà, M, Moreno, L, Prat, A, Ribera, JM, Clèries, R, Guarga, A, Piñol, JAE, Borras, JM. The precision of a report on precision. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-026-04219-6. PMID:41610006. IF:2.500(Q3/6D).
01/03/2026
Subphenotype-and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials
Escrihuela-Vidal, F, Larrauri, JG, López-Contreras, J, Euba, G, Vázquez, A, Gómez-Zorrilla, S, López-Cortés, LE, Gasch, O, Aparicio-Minguijón, E, Escudero-Sànchez, R, Pérez-Rodríguez, MT, Rodríguez-Pardo, D, Jover-Sáenz, A, García-Pardo, G, Rodríguez-Baño, J, Pujol, M, Carratalà, J, Gutiérrez-Gutiérrez, B. Subphenotype-and complication-guided adjunctive fosfomycin versus standard monotherapy in Staphylococcus aureus bacteraemia: pooled analysis of two randomised trials. Lancet Regional Health-Europe. 2026; 62DOI:10.1016/j.lanepe.2026.101611. PMID:41788427. IF:13.000(Q1/1D).
01/03/2026
Avelumab (Ave) in combination with other anticancer agents as first-line maintenance (1LM) treatment for advanced urothelial carcinoma (aUC): Primary analysis from the JAVELIN Bladder Medley phase 2 trial.
Hoffman-Censits, J, Tsiatas, M, Chang, PMH, Kim, M, Zagouri, F, Shin, SJ, Kim, SH, Su, HYL, Arija, JAA, Maroto-Rey, JP, Antonuzzo, L, Maruzzo, M, Tambaro, R, Blais, N, Rottey, S, Gakis, G, Schneider, A, Tyroller, K, Jacob, N, Valderrama, BP. Avelumab (Ave) in combination with other anticancer agents as first-line maintenance (1LM) treatment for advanced urothelial carcinoma (aUC): Primary analysis from the JAVELIN Bladder Medley phase 2 trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.739. PMID:. IF:41.900(Q1/1D).
01/03/2026
Real-world data of enfortumab vedotin in patients with advanced urothelial cancer in Spain: The ENFANTS-GUARD study.
Villarrubia, JE, Fita, MJJ, de Liaño, AG, Cerrillomd, JM, Cruz, P, Anguera, G, Puente, J, Torras, OR, Navarro-Gorro, N, Pinto, A, Ruiz, SG, Cacho, D, Maeso, IG, González, NS, Lainez, N, Herranz, UA, Carrera-Lasfuentes, P, Climent, MA, Macías, NR, Castellano, D. Real-world data of enfortumab vedotin in patients with advanced urothelial cancer in Spain: The ENFANTS-GUARD study.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.700. PMID:. IF:41.900(Q1/1D).
01/03/2026
SEOM-AEEMT consensus on occupational cancer and cancer-associated disability
Mezquita, L, Vicente-Herrero, MT, Cruz, P, de la Torre, MVRI, Hidalgo-Coloma, J, Garcia, LC, Gallego, O, Calvo, A, Martinez, K, Perez-Altozano, J, Molina, R, Garcia-Pardo, M, Gutierrez-Sainz, L, Moreno-Atahonero, E, Ore-Arce, M, Serrano, C, Terradillos-Garcia, MJ, Valero, MR, Reinoso-Barbero, L, Rodriguez, CA, Calvo-Cerrada, B. SEOM-AEEMT consensus on occupational cancer and cancer-associated disability. Clinical & Translational Oncology. 2026; 28(3)DOI:10.1007/s12094-025-04037-2. PMID:40956506. IF:2.500(Q3/6D).
01/03/2026
REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE
Harniman, K, Gessner, C, Bogoevska, V, Russell, R, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Fritz, C, Hahn, A, Trinkmann, F. REAL-WORLD EVIDENCE FOR FIXED TRIPLE THERAPY WITH BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM IN ASTHMA PATIENTS WITH CONCOMITANT COPD: SIX-MONTH RESULTS OF TRIMAXIMIZE. INTERNAL MEDICINE JOURNAL. 2026; 56DOI:. PMID:. IF:1.500(Q2/5D).
01/03/2026
SEPAR Recommendations on Vaccination for Chronic Respiratory Patients
de Miguel-Díez, J, Torres-Castro, R, Herrero, FS, Villanueva, RM, Gómez, BS, Fernández, SQ, Rojo, RP, Cuesta, VMM, Castillo, ME, Fernández, LS, Martínez, MMC, Mediano, O, García-Ortega, A, Rivero, JLG, de la Rosa-Carrillo, D. SEPAR Recommendations on Vaccination for Chronic Respiratory Patients. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(3)DOI:10.1016/j.arbres.2025.06.005. PMID:40592680. IF:9.200(Q1/1D).
01/03/2026
Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils
Merino, A, Barrera, K, Verdú, G, San José, P, Vallbé, M, Molina, A, Rodellar, J. Interpretable Artificial Intelligence Model for the Automatic Identification of Botryoid Neutrophils. International Journal of Laboratory Hematology. 2026; 48DOI:. PMID:. IF:2.300(Q2/5D).
01/03/2026
GRADE Guidance: Update on Developing Good Practice Statements in Guidelines
Dewidar, O, Akl, EA, Morgano, GP, Parmelli, E, Saz-Parkinson, Z, Langendam, MW, Meerpohl, JJ, Marti, M, Mayer, M, Djulbegovic, B, Brignardello-Petersen, R, Chu, DK, Murad, MH, Canelo-Aybar, C, Mathew, JL, Alonso-Coello, P, Qaseem, A, Schwingshackl, L, Bognanni, A, Rojas-Reyes, MX, Morgan, RL, Klugar, M, Comas, DR, Stallings, E, Iorio, A, Tugwell, P, Darzi, A, Turgeon, AF, Shamliyan, TA, Munn, Z, Mathioudakis, AG, Piggott, T, Lotfi, T, Pottie, K, Guyatt, G, Schünemann, HJ. GRADE Guidance: Update on Developing Good Practice Statements in Guidelines. ANNALS OF INTERNAL MEDICINE. 2026; 179(3)DOI:10.7326/ANNALS-25-00431. PMID:41554128. IF:15.200(Q1/1D).
01/03/2026
Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study
Bracchiglione, J, Meza, N, Pieper, D, Lunny, C, Vargas-Peirano, M, Vicuña, J, Briceño, F, Parra, RG, Carrasco, IP, Urrútia, G, Bonfill, X, Madrid, E. Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study. Research Synthesis Methods. 2026; 17(2)DOI:10.1017/rsm.2025.10056. PMID:41635949. IF:6.100(Q1/1D).
01/03/2026
Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership
Metzendorf, MI, Aloosh, M, Benton, L, Perez, JB, Cumpston, M, de'Donato, FK, Laot, S, Piggott, T, Rahman, KMSU, Stein, AT. Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership. Bmj Leader. 2026; 10(1)DOI:10.1136/leader-2025-001277. PMID:40730455. IF:(Q/D).
01/03/2026
Screening for lung cancer: A systematic review of overdiagnosis and its implications
Fernández-Sáenz, FK, de la Torre-Perez, L, Baldwin, DR, van der Aalst, C, Thorat, M, Ritchie, D, Carvalho, AL, Espina, C, Solà, I, Canelo-Aybar, C, Pissinis, MM, Alonso-Coello, P, Pinto, ACPN. Screening for lung cancer: A systematic review of overdiagnosis and its implications. Molecular Oncology. 2026; 20(3)DOI:10.1002/1878-0261.70139. PMID:41220098. IF:4.500(Q2/3D).